risperidone has been researched along with Precancerous Conditions in 1 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Precancerous Conditions: Pathological conditions that tend eventually to become malignant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We found that the two hyperprolactinemia-inducing antipsychotics, risperidone and pimozide, prompted precancerous lesions to progress to cancer while aripiprazole, which did not cause hyperprolactinemia, did not." | 3.88 | Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions. ( Bu, W; Camacho, L; Garcia, S; Hein, S; Hilsenbeck, SG; Johnston, AN; Kapali, J; Li, Y; Nagi, C; Nangia, J; Podsypanina, K; Qin, L; Xue, L, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnston, AN | 1 |
| Bu, W | 1 |
| Hein, S | 1 |
| Garcia, S | 1 |
| Camacho, L | 1 |
| Xue, L | 1 |
| Qin, L | 1 |
| Nagi, C | 1 |
| Hilsenbeck, SG | 1 |
| Kapali, J | 1 |
| Podsypanina, K | 1 |
| Nangia, J | 1 |
| Li, Y | 1 |
1 other study available for risperidone and Precancerous Conditions
| Article | Year |
|---|---|
Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions.
Topics: Animals; Antipsychotic Agents; Apoptosis; Breast; Breast Neoplasms; Cell Differentiation; Female; Hu | 2018 |